609 related articles for article (PubMed ID: 17611934)
21. Effect of acetylcholinesterase oxime-type reactivators K-48 and HI-6 on human liver microsomal cytochromes P450 in vitro.
Veinlichova A; Jancova P; Siller M; Anzenbacher P; Kuca K; Jun D; Fusek J; Anzenbacherova E
Chem Biol Interact; 2009 Aug; 180(3):449-53. PubMed ID: 19539805
[TBL] [Abstract][Full Text] [Related]
22. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats.
Sugiyama T; Kubota Y; Shinozuka K; Yamada S; Wu J; Umegaki K
Life Sci; 2004 Jul; 75(9):1113-22. PubMed ID: 15207658
[TBL] [Abstract][Full Text] [Related]
23. The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel.
Mooiman KD; Maas-Bakker RF; Hendrikx JJ; Bank PC; Rosing H; Beijnen JH; Schellens JH; Meijerman I
J Pharm Pharmacol; 2014 Jun; 66(6):865-74. PubMed ID: 24392691
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes.
Zebothsen I; Kunze T; Clement B
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):37-43. PubMed ID: 16867169
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections.
van den Bout-van den Beukel CJ; Hamza OJ; Moshi MJ; Matee MI; Mikx F; Burger DM; Koopmans PP; Verweij PE; Schoonen WG; van der Ven AJ
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):515-26. PubMed ID: 18331392
[TBL] [Abstract][Full Text] [Related]
27. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Gurley BJ; Swain A; Hubbard MA; Williams DK; Barone G; Hartsfield F; Tong Y; Carrier DJ; Cheboyina S; Battu SK
Mol Nutr Food Res; 2008 Jul; 52(7):755-63. PubMed ID: 18214849
[TBL] [Abstract][Full Text] [Related]
28. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.
Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Cui Y; Ang CY
Drugs Aging; 2005; 22(6):525-39. PubMed ID: 15974642
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
[TBL] [Abstract][Full Text] [Related]
30. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS
Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
[TBL] [Abstract][Full Text] [Related]
31. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies.
Mohamed ME; Frye RF
Planta Med; 2011 Mar; 77(4):311-21. PubMed ID: 21049395
[TBL] [Abstract][Full Text] [Related]
32. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
[TBL] [Abstract][Full Text] [Related]
33. Prediction of herb-drug metabolic interactions: a simulation study.
Zhou S; Huang M; Xu A; Yang H; Duan W; Paxton JW
Phytother Res; 2005 Jun; 19(6):464-71. PubMed ID: 16114078
[TBL] [Abstract][Full Text] [Related]
34. Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum.
Subehan ; Usia T; Kadota S; Tezuka Y
Planta Med; 2006 May; 72(6):527-32. PubMed ID: 16808005
[TBL] [Abstract][Full Text] [Related]
35. Effect of sinomenine on human cytochrome P450 activity.
Yao YM; Cao W; Cao YJ; Cheng ZN; Ou-Yang DS; Liu ZQ; Zhou HH
Clin Chim Acta; 2007 Apr; 379(1-2):113-8. PubMed ID: 17292874
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
[TBL] [Abstract][Full Text] [Related]
37. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of potent CYP2D6 inhibitors in lotus leaves.
Ye LH; He XX; Kong LT; Liao YH; Pan RL; Xiao BX; Liu XM; Chang Q
J Ethnopharmacol; 2014 Apr; 153(1):190-6. PubMed ID: 24561383
[TBL] [Abstract][Full Text] [Related]
39. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.
Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Khan IA; Shah A
Clin Pharmacol Ther; 2005 May; 77(5):415-26. PubMed ID: 15900287
[TBL] [Abstract][Full Text] [Related]
40. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
Nassar AE; King I; Paris BL; Haupt L; Ndikum-Moffor F; Campbell R; Usuki E; Skibbe J; Brobst D; Ogilvie BW; Parkinson A
Drug Metab Dispos; 2009 Sep; 37(9):1922-30. PubMed ID: 19520774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
